Windlas Biotech intimated under SEBI Reg. 30 that the audio recording of its Q4 FY26 earnings conference call is now available on its website.
The call discussed the company's audited consolidated and standalone financial results for the quarter and year ended March 31, 2026.
A transcript of the call will be shared with the stock exchanges and uploaded to the company website in due course.